BIOTRIN INTERNATIONAL'S PARVOVIRUS B19 IGG ENZYME IMMUNOASSAY

Assay,enzyme Linked Immunosorbent,parvovirus B19 Igg

FDA Premarket Approval P970054 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a manufacturing site located at biotrin international ltd in dublin, ireland.

DeviceBIOTRIN INTERNATIONAL'S PARVOVIRUS B19 IGG ENZYME IMMUNOASSAY
Classification NameAssay,enzyme Linked Immunosorbent,parvovirus B19 Igg
Generic NameAssay,enzyme Linked Immunosorbent,parvovirus B19 Igg
ApplicantDIASORIN
Date Received2011-06-24
Decision Date2012-09-05
PMAP970054
SupplementS009
Product CodeMYL
Advisory CommitteeMicrobiology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLocation Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address DIASORIN 1951 Northwestern Avenue stillwater, MN 55082-0285

Supplemental Filings

Supplement NumberDateSupplement Type
P970054Original Filing
S020 2021-11-23 30-day Notice
S019 2020-07-16 30-day Notice
S018 2020-03-30 30-day Notice
S017
S016
S015 2018-08-08 Normal 180 Day Track No User Fee
S014
S013 2017-02-08 30-day Notice
S012 2016-12-22 30-day Notice
S011 2016-02-02 30-day Notice
S010 2013-11-27 30-day Notice
S009 2011-06-24 Normal 180 Day Track No User Fee
S008 2010-02-17 30-day Notice
S007 2009-02-09 30-day Notice
S006 2007-07-31 30-day Notice
S005 2007-06-04 135 Review Track For 30-day Notice
S004 2007-05-14 30-day Notice
S003
S002 2005-03-23 30-day Notice
S001 2002-11-15 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.